Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
25295 | 237 | 42.9 | 78% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1620 | 6498 | PNEUMOCYSTIS CARINII//PNEUMOCYSTIS JIROVECII//PNEUMOCYSTIS CARINII PNEUMONIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | VIETNAM EVIDENCE HLTH POLICY PROJECT | Address | 2 | 43% | 1% | 3 |
2 | CELL PHONE INTERVENTION | Author keyword | 1 | 100% | 1% | 2 |
3 | NON AIDS RELATED MORTALITY | Author keyword | 1 | 100% | 1% | 2 |
4 | PHARMACOTHER Y CHRON DIS MANAGEMENT OUTCOM | Address | 1 | 50% | 1% | 2 |
5 | TOBACCOL | Address | 1 | 100% | 1% | 2 |
6 | PREVALENCE ESTIMATE | Author keyword | 1 | 33% | 1% | 2 |
7 | AIDS DEFINING EVENT | Author keyword | 1 | 50% | 0% | 1 |
8 | BEHAV PREVENT MED PSYCHIAT HUMAN BEH | Address | 1 | 50% | 0% | 1 |
9 | CRE U 897 | Address | 1 | 50% | 0% | 1 |
10 | INFECT DIS HOSP MED | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | POSITIVE SMOKERS | 17 | 100% | 3% | 8 |
2 | HEALTHY CIGARETTE SMOKERS | 14 | 100% | 3% | 7 |
3 | PNEUMOCYSTIS COLONIZATION | 8 | 70% | 3% | 7 |
4 | NEGATIVE VETERANS | 5 | 55% | 3% | 6 |
5 | ANTIRETROVIRAL THERAPY ERA | 4 | 33% | 4% | 10 |
6 | U937 MACROPHAGES | 3 | 60% | 1% | 3 |
7 | CONCURRENT DETERMINATION | 2 | 44% | 2% | 4 |
8 | CESSATION STRATEGIES | 2 | 67% | 1% | 2 |
9 | CO3 AQUITAINE COHORT | 2 | 33% | 2% | 5 |
10 | HAITIAN WOMEN | 1 | 50% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Smoking-Cessation Interventions in People Living With HIV Infection: A Systematic Review | 2014 | 5 | 29 | 72% |
Will expanded ART use reduce the burden of HIV-associated chronic lung disease? | 2014 | 3 | 40 | 30% |
HIV-associated obstructive lung diseases: insights and implications for the clinician | 2014 | 1 | 57 | 49% |
Is smoking tobacco an independent risk factor for HIV infection and progression to AIDS? A systemic review | 2007 | 32 | 19 | 42% |
Interactions between HIV infection and chronic obstructive pulmonary disease: Clinical and epidemiological aspects | 2011 | 5 | 54 | 50% |
How to address smoking cessation in HIV patients | 2015 | 0 | 62 | 56% |
A review of the literature concerning HIV and cigarette smoking: Morbidity and mortality, associations with individual- and social-level characteristics, and smoking cessation efforts | 2015 | 0 | 91 | 47% |
An overlooked majority: HIV-positive gay men who smoke | 2012 | 2 | 66 | 36% |
Smoking and the outcome of infection | 2011 | 40 | 121 | 11% |
Lung function abnormalities in HIV-infected adults and children | 2015 | 0 | 66 | 38% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VIETNAM EVIDENCE HLTH POLICY PROJECT | 2 | 43% | 1.3% | 3 |
2 | PHARMACOTHER Y CHRON DIS MANAGEMENT OUTCOM | 1 | 50% | 0.8% | 2 |
3 | TOBACCOL | 1 | 100% | 0.8% | 2 |
4 | BEHAV PREVENT MED PSYCHIAT HUMAN BEH | 1 | 50% | 0.4% | 1 |
5 | CRE U 897 | 1 | 50% | 0.4% | 1 |
6 | INFECT DIS HOSP MED | 1 | 50% | 0.4% | 1 |
7 | MED PSYCHIAT BIOPHARMACEUT SCI | 1 | 50% | 0.4% | 1 |
8 | PRIMO CI | 1 | 50% | 0.4% | 1 |
9 | RICHARD ROUDEBUSH VA MED | 1 | 50% | 0.4% | 1 |
10 | UNIDAD ENFERMED INFECC | 1 | 50% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000209890 | TOBACCO EXPENDITURE//PREDICTORS OF SMOKING//EXPOSURE TO SECONDHAND SMOKE |
2 | 0.0000208868 | ACQUIRED IMMUNODEFICIENCY SYNDROME PATIENTS//ANTI VZV ANTIBODIES//CRSSAIPSC |
3 | 0.0000127961 | BACTERIAL PNEUMONIA//MALAWI LIVERPOOL WELLCOME PROGRAMME CLIN TROP//DPUO |
4 | 0.0000108140 | PULMONARY KAPOSIS SARCOMA//EXTRAPULMONARY PNEUMOCYSTOSIS//PNEUMOCYSTIS CARINII PNEUMONIA |
5 | 0.0000100178 | AIDS RELATED LYMPHOMA//NON AIDS DEFINING CANCER//NON AIDS DEFINING CANCERS |
6 | 0.0000099000 | LIPODYSTROPHY//LIPOATROPHY//PROGRAM NUTR METAB |
7 | 0.0000094351 | MOS HIV//WHOQOL HIV BREF//WHOQOL HIV |
8 | 0.0000094195 | SMOKING CESSATION//NICOTINE REPLACEMENT THERAPY//VARENICLINE |
9 | 0.0000089019 | HIV RELATED PULMONARY HYPERTENSION//HIV ASSOCIATED CARDIOMYOPATHY//CA2M |
10 | 0.0000074306 | PSYCHOSOCIAL BEHAV MED PROGRAM//ABSTINENCE RATES//UER LYON SUD CHARLES MERIEUX |